2023

1.         Akrami S, Tahmasebi A, Moghadam A, Ramezani A, Niazi A. Integration of mRNA and protein expression data for the identification of potential biomarkers associated with pancreatic ductal adenocarcinoma. Computers in biology and medicine. 2023;157:106529.

2.         Aliabadi A, Haghshenas MR, Kiani R, Koohi-Hosseinabadi O, Purkhosrow A, Pirsalami F, et al. In vitro and in vivo anticancer activity of mebendazole in colon cancer: a promising drug repositioning. Naunyn-Schmiedeberg's archives of pharmacology. 2024;397(4):2379-88.

3.         Alimoradi N, Tahami M, Firouzabadi N, Haem E, Ramezani A. Metformin attenuates symptoms of osteoarthritis: role of genetic diversity of Bcl2 and CXCL16 in OA. Arthritis research & therapy. 2023;25(1):35.

4.         Arefinia N, Yaghobi R, Ramezani A, Sarvari J. Sequence Analysis of Hot Spot Regions of Spike and RNA-dependent-RNA polymerase (RdRp) Genes of SARS-CoV-2 in Kerman, Iran. Mediterranean journal of hematology and infectious diseases. 2023;15(1):e2023042.

5.         Asadi M, Kiani R, Razban V, Faraji SN, Ahmadi A, Fallahi J, et al. Harnessing the Power of CAR-NK Cells: A Promising Off-the-Shelf Therapeutic Strategy for CD38-Positive Malignancies. Iranian journal of immunology : IJI. 2023;20(4):410-26.

6.         Farahani H, Dehghanian AR, Khademolhosseini A, Haghshenas MR, Erfani N. Frequent expression of CD45RO memory T cell marker as well as low to high expression of PD-1 and PD-L1 inhibitory molecules in seminoma and dysgerminoma. Journal of reproductive immunology. 2024;161:104184.

7.         Farjadian F, Faghih Z, Fakhimi M, Iranpour P, Mohammadi-Samani S, Doroudian M. Glucosamine-Modified Mesoporous Silica-Coated Magnetic Nanoparticles: A "Raisin-Cake"-like Structure as an Efficient Theranostic Platform for Targeted Methotrexate Delivery. Pharmaceutics. 2023;15(10).

8.         Fattahi MJ, BH AR, Matsuo H, Cuzzocrea S, Jafarnezhad-Ansariha F, Ahmadi H, et al. Evaluation of cell adhesion molecules (LFA-1 and L-selectin) in ankylosing spondylitis patients after treatment with β-D-mannuronic acid (M2000). The Indian journal of medical research. 2023;157(5):453-9.

9.         Gerdabi S, Asadian F, Kiani R, Khademi B, Haghshenas MR, Erfani N. Simultaneous Expression of PD-1 and PD-L1 in Peripheral and Central Immune Cells and Tumor Cells in the Benign and Malignant Salivary Gland Tumors Microenvironment. Head and neck pathology. 2023;17(1):178-92.

10.       Ghaderi H, Kruger E, Ahmadvand S, Mohammadi Y, Khademi B, Ghaderi A. Epidemiological Profile of Salivary Gland Tumors in Southern Iranian Population: A Retrospective Study of 405 Cases. Journal of cancer epidemiology. 2023;2023:8844535.

11.       Ghoddusi Johari H, Afshari A, Abolhasani Foroughi A, Khademi B, Shahriarirad S, Erfani A, et al. Association of Complications During and After Carotid Body Tumor Resection with Tumor Size and Distance to the Base of Skull. Annals of vascular surgery. 2023;94:223-8.

12.       Golchin A, Ranjbarvan P, Parviz S, Shokati A, Naderi R, Rasmi Y, et al. The role of probiotics in tissue engineering and regenerative medicine. Regenerative medicine. 2023;18(8):635-57.

13.       Haghshenas MR, Ghaderi H, Daneste H, Ghaderi A. Immunological and biological dissection of normal and tumoral salivary glands. International reviews of immunology. 2023;42(2):139-55.

14.       Haghshenas MR, Shiravani Z, Samare-Najaf M, Khansalar S, Razavinasab SA, Ghaderi A, et al. Clinical significance of IL-37 serum level and polymorphism in patients with endometrial cancer. European cytokine network. 2023;34(4):63-9.

15.       Hashemi SMA, Moradi A, Hosseini SY, Razavi Nikoo H, Bamdad T, Faghih Z, et al. A New Insight Into p53-Inhibiting Genes in Epstein–Barr Virus-Associated Gastric Adenocarcinoma. Iranian biomedical journal. 2023;27(1):34-45.

16.       Hashemi SMA, Moradi A, Hosseini SY, Razavi Nikoo H, Bamdad T, Razmkhah M, et al. EBNA1 Upregulates P53-Inhibiting Genes in Burkitt's Lymphoma Cell Line. Reports of biochemistry & molecular biology. 2023;11(4):672-83.

17.       Khademi F, Seghatoleslam A, Ramezani A, Mostafavipour Z, Ghasemi H. Regulation of Epithelial-Mesenchymal Transition by Cyrtopodion Scabrum: An in vitro Study against Colorectal Cancer Cells. Asian Pacific journal of cancer prevention : APJCP. 2023;24(8):2765-72.

18.       Khorami Sarvestani S, Shojaeian S, Sarrami-Forooshani R, Yekaninejad MS, Gilany K, Ghaderi A, et al. Cancer Is Associated with the Emergence of Placenta-Reactive Autoantibodies. Biomedicines. 2023;11(2).

19.       Kia M, Nekooei F, Alipour AH, Hashemi SMA, Salimi V, Fattahi MJ, et al. Investigation of the Seroprevalence of Antimeasles Immunoglobulin G Antibody in Students at Shiraz University of Medical Sciences. Viral immunology. 2023;36(6):424-8.

20.       Maghsoodi N, Zareinejad M, Golestan A, Mahmoudi Maymand E, Ramezani A. Anti-CD19/CD8 bispecific T cell engager for the potential treatment of B cell malignancies. Cellular immunology. 2023;393-394:104787.

21.       Molaei V, Fattahi MR, Haghshenas MR, Hosseini SY, Malekhosseini SA, Sarvari J. Polymorphism Analysis of Interleukin-18 and Interleukin-37 Genes in Hepatitis B Infections with Different Outcomes: A Preliminary Report from an Iranian Population. Asian Pacific journal of cancer prevention : APJCP. 2023;24(2):411-6.

22.       Ramezani A, Zareinejad M, Mahmoudi Maymand E, Kaviani E, Ghaderi A. Production of a biosimilar version of aflibercept to improve VEGF blocker cytotoxicity on endothelial cells. Growth factors (Chur, Switzerland). 2023;41(3):140-51.

23.       Roshan Zamir M, Ariafar A, Ghaderi A, Amirzargar A. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer. Immunobiology. 2023;228(2):152319.

24.       Sajadian M, Khademi B, Moinzadeh L, Ghaderi A, Jafarzadeh A, Razmkhah M. Modulation of semaphorin 3C & 4D expression in cancerous tissues from individuals with laryngeal squamous cell carcinoma. The Indian journal of medical research. 2023;158(4):432-8.

25.       Saleh Z, Mehdipour F, Ataollahi MR, Ali-Hassanzadeh M, Kabelitz D, Kalantar K. Frequency of B-Cell Subpopulations in Low Responders in Comparison with High Responders to Hepatitis B Vaccine Among Health Care Workers. Current microbiology. 2023;80(9):296.

26.       Tabaei S, Haghshenas MR, Ariafar A, Gilany K, Stensballe A, Farjadian S, et al. Comparative proteomics analysis in different stages of urothelial bladder cancer for identification of potential biomarkers: highlighted role for antioxidant activity. Clinical proteomics. 2023;20(1):28.

27.       Tabaei S, Haghshenas MR, Webster TJ, Ghaderi A. Proteomics strategies for urothelial bladder cancer diagnosis, prognosis and treatment: Trends for tumor biomarker sources. Analytical biochemistry. 2023;666:115074.

28.       Tavana S, Mokhtari Z, Sanei MH, Heidari Z, Dehghanian AR, Faghih Z, et al. Clinicopathological significance and prognostic role of LAG3 + tumor-infiltrating lymphocytes in colorectal cancer; relationship with sidedness. Cancer cell international. 2023;23(1):23.

29.       Zamani B, Ramazani A, Saberzadeh J, Rostampour P, Takhshid MA. The effect of Annexin A5 overexpression on invasiveness and expression of the genes involved in epithelial-mesenchymal transition of HCT 116 cell line. Molecular biology research communications. 2023;12(2):77-85.

30.       Zare S, Emami L, Faghih Z, Zargari F, Faghih Z, Khabnadideh S. Design, synthesis, computational study and cytotoxic evaluation of some new quinazoline derivatives containing pyrimidine moiety. Scientific reports. 2023;13(1):14461.

31.       Zareinejad M, Mehdipour F, Roshan-Zamir M, Faghih Z, Ghaderi A. Dual Functions of T Lymphocytes in Breast Carcinoma: From Immune Protection to Orchestrating Tumor Progression and Metastasis. Cancers. 2023;15(19).

32.       Zohouri M, Ghods A, Roshan Zamir M, Shokri F, Ghaderi A. Immune Profiling of SARS-CoV-2; What We Know and What We Don't Know. Iranian journal of allergy, asthma, and immunology. 2023;22(3):217-32.

2022

1.         Arefinia N, Ramezani A, Farokhnia M, Arab Zadeh AM, Yaghobi R, Sarvari J. Association between expression of ZBP1, AIM2, and MDA5 genes and severity of COVID-19. EXCLI journal. 2022;21:1171-83.

2.         Ariafar A, Sanati A, Ahmadvand S, Shekarkhar G, Safaei A, Shayan Z, et al. Prognostic significance of immunoscore related markers in bladder cancer. BMC urology. 2022;22(1):133.

3.         Bagheri Z, Moeinzadeh L, Razmkhah M. Roles of Microbiota in Cancer: From Tumor Development to Treatment. Journal of oncology. 2022;2022:3845104.

4.         Balouchi-Anaraki S, Mohammadsadeghi S, Norouzian M, Rasolmali R, Talei AR, Mehdipour F, et al. Expression of Interleukin-21 and Interleukin-21 receptor in lymphocytes derived from tumor-draining lymph nodes of breast cancer. Breast disease. 2022;41(1):373-82.

5.         Banakar M, Ardekani ST, Zare R, Malekzadeh M, Mirhadi H, Khademi B, et al. Oral Squamous Cell Carcinoma: The Role of BIRC6 Serum Level. BioMed research international. 2022;2022:5425478.

6.         Emami L, Khabnadideh S, Faghih Z, Farahvasi F, Zonobi F, Gheshlaghi SZ, et al. Synthesis, biological evaluation, and computational studies of some novel quinazoline derivatives as anticancer agents. BMC chemistry. 2022;16(1):100.

7.         Fattahi MJ, Haghshenas MR, Ghaderi A. Immunometabolism in the Bladder Cancer Microenvironment. Endocrine, metabolic & immune disorders drug targets. 2022;22(12):1201-16.

8.         Fazeli P, Talepoor AG, Faghih Z, Gholijani N, Ataollahi MR, Ali-Hassanzadeh M, et al. The frequency of CD4+ and CD8+ circulating T stem cell memory in type 1 diabetes. Immunity, inflammation and disease. 2022;10(10):e715.

9.         Gerdabi S, Asadian F, Kiani R, Khademi B, Haghshenas MR, Erfani N. Simultaneous Expression of PD-1 and PD-L1 in Peripheral and Central Immune Cells and Tumor Cells in the Benign and Malignant Salivary Gland Tumors Microenvironment. Head and neck pathology. 2023;17(1):178-92.

10.       Ghods A, Mehdipour F, Rasolmali R, Talei AR, Ghaderi A. TNF-α is produced by, but not limited to, T helper 1, 2, and 17 in breast tumor-draining lymph nodes. Clinical immunology (Orlando, Fla). 2022;245:109140.

11.       Ghods A, Mehdipour F, Rasolmali R, Talei AR, Ghaderi A. The expression pattern of membranous TNF-α is distinct from its intracellular form in breast cancer-draining lymph nodes. Clinical immunology (Orlando, Fla). 2022;238:109026.

12.       Haghshenas MR, Erfani N, Khansalar S, Khademi B, Ashraf MJ, Razmkhah M, et al. Proteomics Study of Mesenchymal Stem Cell-Like Cells Obtained from Tumor Microenvironment of Patients with Malignant and Benign Salivary Gland Tumors. Cell journal. 2022;24(4):196-203.

13.       Haghshenas MR, Saffarian A, Khademolhosseini A, Dehghanian A, Ghaderi A, Sotoodeh Jahromi A. Simultaneous Increase in Serum Levels of IL-37 and IL-18 Binding Protein In Low-Grade and High-Grade Brain Tumors. Asian Pacific journal of cancer prevention : APJCP. 2022;23(8):2851-6.

14.       Haghshenas MR, Zamir MR, Sadeghi M, Fattahi MJ, Mirshekari K, Ghaderi A. Clinical relevance and therapeutic potential of IL-38 in immune and non-immune-related disorders. European cytokine network. 2022;33(3):54-69.

15.       Heidari F, Ramezani A, Erfani N, Razmkhah M. Indoleamine 2, 3-Dioxygenase: A Professional Immunomodulator and Its Potential Functions in Immune Related Diseases. International reviews of immunology. 2022;41(3):346-63.

16.       Hematian Larki M, Ashouri E, Barani S, Ghayumi SMA, Ghaderi A, Rajalingam R. KIR-HLA gene diversities and susceptibility to lung cancer. Scientific reports. 2022;12(1):17237.

17.       Jafarzadeh A, Gosain R, Mortazavi SMJ, Nemati M, Jafarzadeh S, Ghaderi A. SARS-CoV-2 Infection: A Possible Risk Factor for Incidence and Recurrence of Cancers. International journal of hematology-oncology and stem cell research. 2022;16(2):117-27.

18.       Kangari P, Roshangar L, Iraji A, Talaei-Khozani T, Razmkhah M. Accelerating effect of Shilajit on osteogenic property of adipose-derived mesenchymal stem cells (ASCs). Journal of orthopaedic surgery and research. 2022;17(1):424.

19.       Kaviani E, Hosseini A, Mahmoudi Maymand E, Ramzi M, Ghaderi A, Ramezani A. Triggering of lymphocytes by CD28, 4-1BB, and PD-1 checkpoints to enhance the immune response capacities. PloS one. 2022;17(12):e0275777.

20.       Maghsood F, Amiri MM, Zarnani AH, Salimi V, Kardar GA, Khoshnoodi J, et al. Epitope mapping of severe acute respiratory syndrome coronavirus 2 neutralizing receptor binding domain-specific monoclonal antibodies. Frontiers in medicine. 2022;9:973036.

21.       Maghsood F, Shokri MR, Jeddi-Tehrani M, Torabi Rahvar M, Ghaderi A, Salimi V, et al. Identification of immunodominant epitopes on nucleocapsid and spike proteins of the SARS-CoV-2 in Iranian COVID-19 patients. Pathogens and disease. 2022;80(1).

22.       Mazloomrezaei M, Hosseini MS, Ahmadi N, Mahmoudi Maymand E, Eftekhar E, Asgari A, et al. Introducing a New Method for Purification of Human IL-4 by Substitution of a Single Amino Acid in IL-4 Protein Sequence. Iranian journal of immunology : IJI. 2022;19(4):436-45.

23.       Moeinzadeh L, Razeghian-Jahromi I, Zarei-Behjani Z, Bagheri Z, Razmkhah M. Composition, Biogenesis, and Role of Exosomes in Tumor Development. Stem cells international. 2022;2022:8392509.

24.       Moghadasi N, Andisheh-Tadbir A, Samiee A, Torabi Ardekani S, Khademi B, Malekzadeh M, et al. Profile of Serum Heat Shock Protein-27 Level in Patients with Salivary Gland Tumor. Journal of dentistry (Shiraz, Iran). 2022;23(3):251-6.

25.       Mohammadi Y, Ahmadvand S, Mirtalebi M, Ashraf MJ, Khademi B, Ghaderi A. CD45RO+TILs: cellular biomarkers for larynx squamous cell carcinoma outcome. Brazilian journal of otorhinolaryngology. 2022;88 Suppl 4(Suppl 4):S133-s42.

26.       Namvar N, Montazer M, Ahmadvand S, Sadeghian B, Ghaderi A. Expression of PD-1 in Tumor Cells is Associated with Shorter Survival in Non-metastatic Intestinal-type Gastric Adenocarcinoma. Iranian journal of allergy, asthma, and immunology. 2022;21(6):600-15.

27.       Nejabat S, Haghshenas MR, Farjadian S. Allergenome profiling of Vespa orientalis venom by serum IgE in patients with anaphylactic reaction to this hornet sting. Toxicon : official journal of the International Society on Toxinology. 2022;214:130-5.

28.       Niknam K, Safaei A, Ghaderi A. Evaluation of the Prognostic Value of CD56 (140 kDa Isoform) Expression in Breast Cancer Tissues: an Eight-Year Retrospective Study. Iranian biomedical journal. 2022;26(3):175-82.

29.       Norouzian M, Mehdipour F, Ashraf MJ, Khademi B, Ghaderi A. Regulatory and effector T cell subsets in tumor-draining lymph nodes of patients with squamous cell carcinoma of head and neck. BMC immunology. 2022;23(1):56.

30.       Razeghian-Jahromi I, Karimi Akhormeh A, Razmkhah M, Zibaeenezhad MJ. Immune system and atherosclerosis: Hostile or friendly relationship. International journal of immunopathology and pharmacology. 2022;36:3946320221092188.

31.       Rezaei S, Azarpira N, Koohpeyma F, Yousefi R, Doaei S, Heidari M, et al. Evaluation of morphology and angiogenesis of breast cancer in BALB/c mice using trypsin inhibitor from Cucumis melo seeds. In vitro and in vivo study. Contemporary oncology (Poznan, Poland). 2022;26(3):204-19.

32.       Rezayatmand H, Razmkhah M, Razeghian-Jahromi I. Drug resistance in cancer therapy: the Pandora's Box of cancer stem cells. Stem cell research & therapy. 2022;13(1):181.

33.       Roshan Zamir M, Ariafar A, Ghaderi A, Amirzargar A. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer. Immunobiology. 2023;228(2):152319.

34.       Rostamzadeh D, Haghshenas MR, Samadi M, Mojtahedi Z, Babaloo Z, Ghaderi A. Immunosuppressive Effects and Potent Anti-tumor Efficacy of mTOR Inhibitor Everolimus in Breast Tumor-bearing Mice. Iranian journal of allergy, asthma, and immunology. 2022;21(3):287-99.

35.       Salmanpour A, Rezaeifard S, Kiani R, Tahmasebi S, Faghih Z, Erfani N. IFNγ-IL-17-IL-22+CD4+ subset and IL-22-producing cells in tumor draining lymph nodes of patients with breast cancer. Breast disease. 2022;41(1):383-90.

36.       Sani M, Hosseinie R, Latifi M, Shadi M, Razmkhah M, Salmannejad M, et al. Engineered artificial articular cartilage made of decellularized extracellular matrix by mechanical and IGF-1 stimulation. Biomaterials advances. 2022;139:213019.

37.       Soltan-Alinejad P, Alipour H, Soltani A, Asgari Q, Ramezani A, Mehrabani D, et al. Molecular Characterization and In Silico Analyses of Maurolipin Structure as a Secretory Phospholipase A (2) (sPLA(2)) from Venom Glands of Iranian Scorpio maurus (Arachnida: Scorpionida). Journal of tropical medicine. 2022;2022:1839946.

38.       Taeb S, Mosleh-Shiraz MA, Ghaderi A, Mortazavi SMJ, Razmkhah M. Adipose-Derived Mesenchymal Stem Cells Responses to Different Doses of Gamma Radiation. Journal of biomedical physics & engineering. 2022;12(1):35-42.

39.       Vakili ME, Faghih Z, Sarvari J, Doroudchi M, Hosseini SN, Kabelitz D, et al. Lower frequency of T stem cell memory (TSCM) cells in hepatitis B vaccine nonresponders. Immunologic research. 2022;70(4):469-80.

40.       Zangouri V, Nasrollahi H, Taheri A, Akrami M, Arasteh P, Hamedi SH, et al. Intraoperative radiation therapy for early stage breast cancer. BMC surgery. 2022;22(1):26.

2021

1.         Ariafar A, Habibagahi M, Jaberipour M, Khezri A, Hadi Khezri M, Bozorgi H, et al. Upregulation of Cytotoxic T-Lymphocyte-Associated Protein 4 and Forkhead Box P3 Transcripts in Peripheral Blood of Patients with Bladder Cancer. Iranian journal of medical sciences. 2021;46(5):339-46.

2.         Ariafar A, Zareinejad M, Soltani M, Vahidi Y, Faghih Z. GM-CSF-producing lymphocytes in tumor-draining lymph nodes of patients with bladder cancer. European cytokine network. 2021;32(1):1-7.

3.         Asadi M, Ahmadi N, Ahmadvand S, Jafari AA, Safaei A, Erfani N, et al. Investigation of olfactory receptor family 51 subfamily j member 1 (OR51J1) gene susceptibility as a potential breast cancer-associated biomarker. PloS one. 2021;16(2):e0246752.

4.         Asadipour M, Fazeli P, Zohouri M, Bemani P, Mohebbiniya M, Khansalar S, et al. IL-18 in Blood Serum of Hepatitis C Patients Might be of Predictive Value for Individual Outcomes. Infectious disorders drug targets. 2021;21(3):389-93.

5.         Ashouri E, Rajalingam K, Barani S, Farjadian S, Ghaderi A, Rajalingam R. Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk. Scientific reports. 2021;11(1):7932.

6.         Balouchi-Anaraki S, Ahmadvand S, Safaei A, Ghaderi A. 4H12, a Murine Monoclonal Antibody Directed against Myosin Heavy Chain-9 Expressed on Acinar Cell Carcinoma of Pancreas with Potential Therapeutic Application. Iranian biomedical journal. 2021;25(5):310-22.

7.         Beizavi Z, Zohouri M, Asadipour M, Ghaderi A. IL-27, a pleiotropic cytokine for fine-tuning the immune response in cancer. International reviews of immunology. 2021;40(5):319-29.

8.         Dorosti H, Nezafat N, Heidari R, Ghoshoon MB, Gholami A, Dehshahri A, et al. Production and Immunological Evaluation of Epitope-based Preventative Pneumococcal Candidate Vaccine Comprising Immunodominant Epitopes from PspA, CbpA, PhtD and PiuA Antigens. Current pharmaceutical biotechnology. 2021;22(14):1900-9.

9.         Faghih Z, Taherifard E, Daneshmand A, Talei A, Erfani N. OX40 genetic variations in patients with breast cancer: a case-control study. British journal of biomedical science. 2021;78(1):44-6.

10.       Ghahartars M, Abtahi S, Zeinali Z, Fattahi MJ, Ghaderi A. Investigation of TNF-α and IL-6 Levels in the Sera of Non-Melanoma Skin Cancer Patients. Iranian biomedical journal. 2021;25(2):88-92.

11.       Ghahartars M, Sedaghat F, Khajavi E, Nejat AA, Malekzadeh M, Ghaderi A, et al. Investigation of IL-17A Serum Levels in Patients with Nonmelanoma Skin Cancer. Dermatology research and practice. 2021;2021:5540163.

12.       Ghods A, Ghaderi A, Mehdipour F. Expression of TNFRs by B and T Lymphocytes in Tumor-Draining Lymph Nodes. Methods in molecular biology (Clifton, NJ). 2021;2248:259-69.

13.       Ghods A, Mehdipour F, Shariat M, Talei AR, Ghaderi A. Regulatory T cells express Tumor Necrosis Factor Receptor 2 with the highest intensity among CD4(+) T cells in the draining lymph nodes of breast cancer. Mol Immunol. 2021;137:52-6.

14.       Haghshenas MR, Ghaderi H, Daneste H, Ghaderi A. Immunological and biological dissection of normal and tumoral salivary glands. International reviews of immunology. 2023;42(2):139-55.

15.       Haghshenas MR, Hosseini SR, Fattahi MJ, Malekzadeh M, Ariafar A, Ghaderi A. Elevated IL-37 Serum Levels in Patients with Transitional Cell Carcinoma of Bladder. Iranian journal of immunology : IJI. 2021;18(4):346-53.

16.       Hashemi S, Jassbi AR, Erfani N, Kiani R, Seradj H. Two new cytotoxic ursane triterpenoids from the aerial parts of Salvia urmiensis Bunge. Fitoterapia. 2021;154:105030.

17.       Heidari F, Razmkhah M, Razban V, Erfani N. Effects of indoleamine 2, 3-dioxygenase (IDO) silencing on immunomodulatory function and cancer-promoting characteristic of adipose-derived mesenchymal stem cells (ASCs). Cell biology international. 2021;45(12):2544-56.

18.       Maleksabet A, Zarei Jaliani H, Asgari A, Ramezani A, Erfani N. Specific Targeting of Recombinant Human Pancreatic Ribonuclease 1 using Gonadotropin-Releasing Hormone Targeting Peptide toward Gonadotropin-Releasing Hormone Receptor-Positive Cancer Cells. Iranian journal of medical sciences. 2021;46(4):281-90.

19.       Nasrollahi H, Khaki S, Ansari M, Ahmadloo N, Khanjani N, Hamedi SH, et al. Evaluation of Mucosamin Effect on Treating Radiation Induced Oral Mucositis during and after Radiotherapy amongst Patients with Oral Cavity Squamous Cell Carcinoma. Asian Pacific journal of cancer prevention : APJCP. 2021;22(11):3711-5.

20.       Nazari N, Jafari F, Ghalamfarsa G, Hadinia A, Atapour A, Ahmadi M, et al. The emerging role of microRNA in regulating the mTOR signaling pathway in immune and inflammatory responses. Immunology and cell biology. 2021;99(8):814-32.

21.       Pourahmad S, Foroozani S, Nourelahi M, Hosseini A, Razmkhah M. Evaluation of Twenty Genes in Prognosis of Patients with Ovarian Cancer Using Four Different Clustering Methods. Asian Pacific journal of cancer prevention : APJCP. 2021;22(6):1781-7.

22.       Ramezani A. CtNorm: Real time PCR cycle of threshold (Ct) normalization algorithm. Journal of microbiological methods. 2021;187:106267.

23.       Ramezani A, Asgari A, Kaviani E, Hosseini A, Ghaderi A. Tatibody, a recombinant antibody with higher internalization potency. Mol Immunol. 2021;135:320-8.

24.       Razeghian-Jahromi I, Matta AG, Canitrot R, Zibaeenezhad MJ, Razmkhah M, Safari A, et al. Surfing the clinical trials of mesenchymal stem cell therapy in ischemic cardiomyopathy. Stem cell research & therapy. 2021;12(1):361.

25.       Razeghian-Jahromi I, Zibaeenezhad MJ, Lu Z, Zahra E, Mahboobeh R, Lionetti V. Angiotensin-converting enzyme 2: a double-edged sword in COVID-19 patients with an increased risk of heart failure. Heart failure reviews. 2021;26(2):371-80.

26.       Rezaeifard S, Heike Y, Masuyama JI, Rezvani A, Vojdani R, Erfani N. Autologous Natural Killer Cell-enrichment for Immune Cell Therapy: Preclinical Setting Phase, Shiraz Experience. Iranian journal of allergy, asthma, and immunology. 2021;20(2):233-43.

27.       Rezaeifard S, Talei A, Shariat M, Erfani N. Tumor infiltrating NK cell (TINK) subsets and functional molecules in patients with breast cancer. Mol Immunol. 2021;136:161-7.

28.       Shadmani A, Razmkhah M, Jalalpoor MH, Lari SY, Eghtedari M. Autologous Activated Omental versus Allogeneic Adipose Tissue-Derived Mesenchymal Stem Cells in Corneal Alkaline Injury: An Experimental Study. Journal of current ophthalmology. 2021;33(2):136-42.

29.       Taeb S, Mosleh-Shirazi MA, Ghaderi A, Mortazavi SMJ, Razmkhah M. Radiation-Induced Bystander Effects of Adipose-Derived Mesenchymal Stem Cells. Cell journal. 2021;23(6):612-8.

30.       Zareinejad M, Faghih Z, Ariafar A, Safaei A, Ghaderi A. Establishment of a bladder cancer cell line expressing both mesenchymal and epithelial lineage-associated markers. Human cell. 2021;34(2):675-87.

31.       Zohouri M, Mehdipour F, Razmkhah M, Faghih Z, Ghaderi A. CD4(+)CD25(-)FoxP3(+) T cells: a distinct subset or a heterogeneous population? International reviews of immunology. 2021;40(4):307-16.

2020

 

1.     Alicata C., Ashouri E., Nemat-Gorgani N., Guethlein L. A., Marin W. M., et al. KIR Variation in Iranians Combines High Haplotype and Allotype Diversity With an Abundance of Functional Inhibitory Receptors. Frontiers in immunology,2020; 11:556

 

2.     Ariafar A., Ghaedi M., Rezaeifard S., Shahriari S., Zeighami S., et al. Clinical relevance and prognostic significance of PD-1/PD-Ls in non-metastatic bladder cancer: A role for PD-L2. Molecular immunology, 2020; 124:35-41

 

3.     Ariafar A., Vahidi Y., Fakhimi M., Asadollahpour A., Erfani N., Faghih Z. Prognostic significance of CD4-positive regulatory T cells in tumor draining lymph nodes from patients with bladder cancer. Heliyon, 2020; 6.e05556

 

4.     Asadipour M., Fazeli P., Zohouri M., Bemani P., Mohebbiniya M., et al. IL-18 in Blood Serum of Hepatitis C Patients Might be of Predictive Value for Individual Outcomes. Infectious disorders drug targets2020

 

5.     Barani S., Khademi B., Ghaderi A. KIR2DS4, KIR2DL2, and KIR2DS4del are linked with basaloid tumors, lymph node metastasis, advanced stage and metastatic risk in head and neck squamous cell carcinoma. Experimental and molecular pathology, 2020; 112:104345

 

6.     Barani S., Taghipour M., Ghaderi A. Positive association of Bx genotype, KIR2L5, KIR2DS5 and full-length KIR2DS4 with the risk of meningioma. Immunobiology, 2020; 225:151900

 

7.     Beizavi Z., Zohouri M., Asadipour M., Ghaderi A. IL-27, a pleiotropic cytokine for fine-tuning the immune response in cancer. International reviews of immunology, 2020; 1-11

 

8.     Dehghani Nazhvani A., Sarafraz N., Askari F., Heidari F., Razmkhah M. Anti-Cancer Effects of Traditional Medicinal Herbs on Oral Squamous Cell Carcinoma. Asian Pacific journal of cancer prevention : APJCP, 2020; 21:479-84

 

9.     Fakhimi M., Talei A. R., Ghaderi A., Habibagahi M., Razmkhah M. Helios, CD73 and CD39 Induction in Regulatory T Cells Exposed to Adipose Derived Mesenchymal Stem Cells. Cell journal, 2020; 22:236-44

 

10.   Haghighi A. H., Khorasani M. T., Faghih Z., Farjadian F. Effects of different quantities of antibody conjugated with magnetic nanoparticles on cell separation efficiency. Heliyon,2020; 6.e03677

 

11.   Heidari F., Ramezani A., Erfani N., Razmkhah M. Indoleamine 2, 3-Dioxygenase: A Professional Immunomodulator and Its Potential Functions in Immune Related Diseases. International reviews of immunology, 2020; 1-18

 

12.   Hematian Larki M., Barani S., Talei A. R., Ghaderi A. Diversity of KIRs in invasive breast cancer patients and healthy controls along with the clinical significance in ER/PR/HER2+ patients. Genes and immunity, 2020; 21.380-9

 

13.   Kangari P., Talaei-Khozani T., Razeghian-Jahromi I., Razmkhah M. Mesenchymal stem cells: amazing remedies for bone and cartilage defects. Stem cell research & therapy, 2020; 11.492

 

14.   Karimzadeh P., Faghih Z., Rahmani N., Eghbali F., Razmkhah M. Quantification of angiogenic factors and their clinicopathological associations in breast cancer. European cytokine network, 2020; 31:68-75

 

15.   Shamsdin S. A., Alborzi A., Ghaderi A., Lankrani K. B., Pouladfar G.R. Significance of TC9 and TH9 in Helicobacter pylori-induced gastritis. Helicobacter, 2020; 25.e12672

 

16.   Shariati S., Ghods A., Zohouri M., Rasolmali R., Talei A. R., et al. Significance of TIM-3 expression by CD4(+) and CD8(+) T lymphocytes in tumor-draining lymph nodes from patients with breast cancer. Molecular immunology, 2020; 128:47-54

 

17.   Shariati S., Mehdipour F., Samadi M., Rasolmali R., Talei A. R., Ghaderi A. The balance of regulatory and stimulatory B cell subsets in breast cancer draining lymph nodes correlates with tumor prognostic factors. Life sciences, 2020; 257:118117

 

18.   Tavangar M. S., Attar A., Razmkhah M., Hosseini S. M., Hosseini A., et al. Differential expression of drug resistance genes in CD146 positive dental pulp derived stem cells and CD146 negative fibroblasts. Clinical and experimental dental research, 2020; 6:448-56

 

19.   Vahidi Y., Bagheri M., Ghaderi A., Faghih Z. CD8-positive memory T cells in tumor-draining lymph nodes of patients with breast cancer. BMC cancer, 2020; 20:257

 

20.   Zohouri M., Ghaderi A. The Significance of Biobanking in the Sustainability of Biomedical Research: A Review. Iranian biomedical journal, 2020; 24:206-13

 

21.   Zohouri M., Ghaderi A. Biobank; An Essential Infrastructure for the Future of Personalized Medicine. Archives of Iranian medicine, 2020; 23:59-60

 

22.   Zohouri M., Mehdipour F., Razmkhah M., Faghih Z., Ghaderi A. CD4(+)CD25(-)FoxP3(+) T cells: a distinct subset or a heterogeneous population? International reviews of immunology,2020; 1-10

 

 

2019

 

 

 

1.         Abtahi S., Hakimrabet S., Malekzadeh M., Deghanian A. R., Ghaderi A. Investigating the Levels of Soluble Extracellular Domain of HER2 Protein in the Sera of Meningioma Patients. Turkish neurosurgery, 2019; 29:9-13

2.     Ahmadvand S., Faghih Z., Montazer M., Safaei A., Mokhtari M., et al. Importance of CD45RO+ tumor-infiltrating lymphocytes in post-operative survival of breast cancer patients. Cellular oncology (Dordrecht), 2019; 42:343-56

3.     Arabpour M., Rasolmali R., Talei A. R., Mehdipour F., Ghaderi A. Granzyme B production by activated B cells derived from breast cancer-draining lymph nodes. Molecular immunology, 2019; 114:172-8

4.     Asgari A., Sharifzadeh S., Ghaderi A., Hosseini A., Ramezani A. In vitro cytotoxic effect of Trastuzumab in combination with Pertuzumab in breast cancer cells is improved by interleukin-2 activated NK cells. Molecular biology reports, 2019; 46:6205-13

5.     Barani S., Hosseini S. V., Ghaderi A. Activating and inhibitory killer cell immunoglobulin like receptors (KIR) genes are involved in an increased susceptibility to colorectal adenocarcinoma and protection against invasion and metastasis. Immunobiology, 2019; 224:681-6

6.     Chatrabnous N., Ghaderi A., Ariafar A., Razeghinia M. S. Nemati M., Jafarzadeh A.,Serum concentration of interleukin-35 and its association with tumor stages and FOXP3 gene polymorphism in patients with prostate cancer. Cytokine, 2019; 113:221-7

7.     Chatrabnous N., Jafarzadeh A., Ghaderi A., Ariafar A. , Aminizadeh N., et al. Association of elevated interleukin-33 serum levels with tumorstages in patients with prostate cancer. European cytokine network, 2019; 30:144-50

8.     Faghih Z., Abtahi S., Khademi B., Nikfarjam F., Erfani N. Association of OX40 gene polymorphisms (rs17568G/A and rs229811A/C) with head and neck squamous cell carcinoma. Molecular biology reports, 2019; 46:2609-16

9.     Fathi F., Faghih Z., Khademi B., Kayedi T., Erfani N., Gahderi A. PD-1 Haplotype Combinations and Susceptibility of Patients to Squamous Cell Carcinomas of Head and Neck. Immunological investigations, 2019; 48:1-10

10.   Ghaderi F., Mehdipour F., Hosseini A., Talei A., Ghaderi A. Establishment and Characterization of a New Triple Negative Breast Cancer Cell Line from an Iranian Breast Cancer Tissue. Asian Pacific journal of cancer prevention : APJCP, 2019; 20:1683-9

11.   Ghods A., Ghaderi A., Shariat M., Talei A. R., Mehdipour F. TNFR2 but not TNFR1 is the main TNFR expressed by B and T lymphocytes in breast cancer draining lymph nodes. .Immunology letters, 2019; 209:36-44

12.   Jaafari-Ashkvandi Z., Shirazi S. Y., Rezaeifard S., Hamedi A., Erfani N. Cytotoxic Effects of Pistacia Atlantica (Baneh) Fruit Extract on Human KB Cancer Cell Line. Acta medica (Hradec Kralove), 2019; 62:30-4

13.   Mansourabadi Z., Razmkhah M., Mohtasebi M. S., Talei A. R., Ghaderi A. Expression of major histocompatibility complex class I polypeptide-related sequence B in adipose-derived stem cells from breast cancer patients and normal individuals. Journal of cancer research and therapeutics, 2019; 15:1067-72

14.   Masoud Y., Ramin S., Mahboobeh R., Mehrnoosh M., Fahimeh J., Parastoo K. Effect of Lithium and Valproate on Proliferation and Migration of Limbal Epithelial Stem/Progenitor Cells. Current eye research, 2019; 44:154-61

15.   Mehdipour F., Razmkhah M., Faghih Z., Bagheri M., Talei A. R., Ghaderi A. The significance of cytokine-producing B cells in breast tumor-draining lymph nodes. Cellular oncology (Dordrecht), 2019; 42:381-95

16.   Niakan A., Faghih Z., Talei A. R., Ghaderi A. Cytokine profile of CD4(+)CD25(-)FoxP3(+) T cells in tumor-draining lymph nodes from patients with breast cancer. Molecular immunology, 2019; 116:90-7

17.   Norouzian M., Mehdipour F., Balouchi Anaraki S., Ashraf M. J., Khademi B., Ghaderi A. Atypical Memory and Regulatory B Cell Subsets in Tumor Draining Lymph Nodes of Head and Neck Squamous Cell Carcinoma Correlate with Good Prognostic Factors. Head and neck pathology,2019;

18.   Razmkhah M., Abtahi S., Ghaderi A. Mesenchymal Stem Cells, Immune Cells and Tumor Cells Crosstalk: A Sinister Triangle in the Tumor Microenvironment. Current stem cell research & therapy, 2019; 14:43-51

19.   Rezaeifard S., Safaei A., Talei A., Faghih Z., Erfani N. NK, NKT and Invariant-NKT Cells in Tumor Draining Lymph Nodes of Patients with Breast Cancer. Iranian Journal of Immunology : IJI, 2019; 16:291-8

20.   Rostamzadeh D., Haghshenas M. R., Daryanoosh F., Samadi M., Hosseini A., et al. Altered frequency of CD8(+) CD11c(+) T cells and expression of immunosuppressive molecules in lymphoid organs of mouse model of colorectal cancer. Journal of Cellular Physiology, 2019; 234:11986-98

21.   Toghraie F. S., Yazdanpanah-Samani M., Mahmoudi Maymand E., Hosseini A., Asgari A., et al. Molecular Cloning, Expression and Purification of G-CSF Isoform D, an Alternative Splice Variant of Human G-CSF. Iranian journal of allergy, asthma, and immunology, 2019; 18:419-26  

 

2018

 

1.            Abtahi S, Asadipour M, Ghaderi A. The Legacy of Mesenchymal Stem Cells in Vindicating the Clonal Evolution Model of Cancer. Asian Pacific journal of cancer prevention : APJCP. 2018;19(8):2029-30.

2.            Abtahi S, Izadi Jahromi F, Dabbaghmanesh MH, Malekzadeh M, Ghaderi A. Association between CTLA-4 + 49A > G and - 318C > T single-nucleotide polymorphisms and susceptibility to thyroid neoplasm. Endocrine. 2018;62(1):159-65.

3.            Abtahi S, Malekzadeh M, Nikravan G, Ghaderi A. Measurement of Lung Cancer Tumor Markers in a Glass Wool Company Workers Exposed to Respirable Synthetic Vitreous Fiber and Dust. The international journal of occupational and environmental medicine. 2018;9(1):23-31.

4.            Alireza Bolourian AS, Mojtahedi Z. Blocking natural killer cells in testicular torsion may prevent autoimmunity against low expressing major histocompatibility complex class I germ cells. The Indian journal of medical research. 2018;147(2):128-31.

5.            Barani S, Khademi B, Ashouri E, Ghaderi A. KIR2DS1, 2DS5, 3DS1 and KIR2DL5 are associated with the risk of head and neck squamous cell carcinoma in Iranians. Human immunology. 2018;79(4):218-23. Epub 2018/02/07.

6.            Bolourian A, Mojtahedi Z. Streptomyces, shared microbiome member of soil and gut, as 'old friends' against colon cancer. FEMS microbiology ecology. 2018;94(8).

7.            Bolourian A, Mojtahedi Z. Immunosuppressants produced by Streptomyces: evolution, hygiene hypothesis, tumour rapalog resistance and probiotics. Environmental microbiology reports. 2018;10(2):123-6.

8.            Faghih Z, Deihimi S, Talei A, Ghaderi A, Erfani N. Analysis of T cell receptor repertoire based on Vbeta chain in patients with breast cancer. Cancer biomarkers : section A of Disease markers. 2018;22(4):733-45.

9.            Ghaderi A, Abtahi S. Mesenchymal Stem Cells: Miraculous Healers or Dormant Killers? Stem cell reviews. 2018;14(5):722-33.

10.          Ghaderi F, Ahmadvand S, Ramezani A, Montazer M, Ghaderi A. Production and characterization of monoclonal antibody against a triple negative breast cancer cell line. Biochemical and biophysical research communications. 2018;505(1):181-6.

11.          Ghaderi H, Razmkhah M, Kiany F, Chenari N, Haghshenas MR, Ghaderi A. Comparison of Osteogenic and Chondrogenic Differentiation Ability of Buccal Fat Pad Derived Mesenchymal Stem Cells and Gingival Derived Cells. Journal of dentistry (Shiraz, Iran). 2018;19(2):124-31.

12.          Jamali E, Barani S, Yousefinejad F, Ariafar A, Talei GR, Ghaderi A. KIRs gene content diversity in Iranians with urothelial bladder cancer. Molecular biology reports. 2018;45(5):713-9.

13.          Kavousipour S, Mokarram P, Gargari SLM, Mostafavi-Pour Z, Barazesh M, Ramezani A, et al. A Comparison Between Cell, Protein and Peptide-Based Approaches for Selection of Nanobodies Against CD44 from a Synthetic Library. Protein and peptide letters. 2018;25(6):580-8.

14.          Lavaee F, Zare S, Mojtahedi Z, Malekzadeh M, Khademi B, Ghaderi A. Serum CXCL12, but not CXCR4, Is Associated with Head and Neck Squamous Cell Carcinomas. Asian Pacific journal of cancer prevention : APJCP. 2018;19(4):901-4.

15.          Mehdipour F, Razmkhah M, Rezaeifard S, Bagheri M, Talei AR, Khalatbari B, et al. Mesenchymal stem cells induced anti-inflammatory features in B cells from breast tumor draining lymph nodes. Cell biology international. 2018.

16.          Negahdaripour M, Nezafat N, Eslami M, Ghoshoon MB, Shoolian E, Najafipour S, et al. Structural vaccinology considerations for in silico designing of a multi-epitope vaccine. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2018;58:96-109.

17.          Ramezani A, Ghaderi A. Using a Dihydrofolate Reductase-Based Strategy for Producing the Biosimilar Version of Pertuzumab in CHO-S Cells. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2018;37(1):26-37.

18.          Razmkhah M, Abtahi S, Ghaderi A. Mesenchymal stem cells, immune cells and tumor cells cross talk: A sinister triangle in the tumor microenvironment. Current stem cell research & therapy. 2018.

19.          Razmkhah M, Mansourabadi Z, Mohtasebi MS, Talei AR, Ghaderi A. Cancer and normal adipose-derived mesenchymal stem cells (ASCs): Do they have differential effects on tumor and immune cells? Cell biology international. 2018;42(3):334-43.

20.          Rezaei M, Nikeghbalian S, Mojtahedi Z, Ghaderi A. Identification of antibody reactive proteins in pancreatic cancer using 2D immunoblotting and mass spectrometry. Oncology reports. 2018;39(5):2413-21.

21.          Shaaban Z, Jafarzadeh Shirazi MR, Nooranizadeh MH, Tamadon A, Rahmanifar F, Ahmadloo S, et al. Decreased Expression of Arginine-Phenylalanine-Amide-Related Peptide-3 Gene in Dorsomedial Hypothalamic Nucleus of Constant Light Exposure Model of Polycystic Ovarian Syndrome. International journal of fertility & sterility. 2018;12(1):43-50.

22.          Vahidi Y, Faghih Z, Talei AR, Doroudchi M, Ghaderi A. Memory CD4(+) T cell subsets in tumor draining lymph nodes of breast cancer patients: A focus on T stem cell memory cells. Cellular oncology (Dordrecht). 2018;41(1):1-11.

23.          Vakili B, Eslami M, Hatam GR, Zare B, Erfani N, Nezafat N, et al. Immunoinformatics-aided design of a potential multi-epitope peptide vaccine against Leishmania infantum. International journal of biological macromolecules. 2018;120(Pt A):1127-39.

24.          Vakili B, Nezafat N, Hatam GR, Zare B, Erfani N, Ghasemi Y. Proteome-scale identification of Leishmania infantum for novel vaccine candidates: A hierarchical subtractive approach. Computational biology and chemistry. 2018;72:16-25.

25.          Zargar P, Ghani E, Mashayekhi FJ, Ramezani A, Eftekhar E. Acriflavine enhances the antitumor activity of the chemotherapeutic drug 5-fluorouracil in colorectal cancer cells. Oncology letters. 2018;15(6):10084-90.

 

2017

1.            Abtahi S, Davani F, Mojtahedi Z, Hosseini SV, Bananzadeh A, Ghaderi A. Dual association of serum interleukin-10 levels with colorectal cancer. Journal of cancer research and therapeutics. 2017;13(2):252-6.

2.            Abtahi S, Hakimrabet S, Malekzadeh M, Deghanian AR, Ghaderi A. Investigating the levels of soluble extracellular domain of HER2 protein in the sera of meningioma patients. Turkish neurosurgery. 2017.

3.            Bahrami B, Hosseini A, Talei AR, Ghaderi A, Razmkhah M. Adipose Derived Stem Cells Exert Immunomodulatory Effects on Natural Killer Cells in Breast Cancer. Cell journal. 2017;19(1):137-45.

4.            Bamdad S, Khademi B, Chenari N, Taseh A, Razmkhah M. Stromal cell derived factor-1, CXCR4 and CXCR7 gene transcripts in pterygia. Journal of current ophthalmology. 2017;29(1):28-32.

5.            Bolourian A, Mojtahedi Z. Possible damage to immune-privileged sites in natural killer cell therapy in cancer patients: side effects of natural killer cell therapy. Immunotherapy. 2017;9(3):281-8.

6.            Dowran R, Sarvari J, Moattari A, Fattahi MR, Ramezani A, Hosseini SY. Analysis of TLR7, SOCS1 and ISG15 immune genes expression in the peripheral blood of responder and non-responder patients with chronic Hepatitis C. Gastroenterology and hepatology from bed to bench. 2017;10(4):272-7.

7.            Esmailbeig M, Ghaderi A. Interleukin-18: a regulator of cancer and autoimmune diseases. European cytokine network. 2017;28(4):127-40.

8.            Faghihi SA, Khankeh HR, Hosseini SJ, Soltani Arabshahi SK, Faghih Z, Shirazi M. Impractical CME programs: Influential parameters in Iran. Medical journal of the Islamic Republic of Iran. 2017;31:6.

9.            Fereidoonnezhad M, Niazi M, Shahmohammadi Beni M, Mohammadi S, Faghih Z, Faghih Z, et al. Synthesis, Biological Evaluation, and Molecular Docking Studies on the DNA Binding Interactions of Platinum(II) Rollover Complexes Containing Phosphorus Donor Ligands. ChemMedChem. 2017;12(6):456-65.

10.          Ghalamfarsa G, Hosseini SV, Hamidinia M, Ghaderi A, Mahmoudi M, Mojtahedi Z. Differential Immune Reactivity Pattern of SW48 and SW1116 Colorectal Cancer Cell Lines with Colorectal Cancer Patients Sera. Advanced biomedical research. 2017;6:6.

11.          Golestan A, Ghaderi A, Mojtahedi Z. Effects of NDRG2 Overexpression on Metastatic Behaviors of HCT116 Colorectal Cancer Cell Line. Advanced pharmaceutical bulletin. 2017;7(4):661-4.

12.          Haghshenas MR, Ashraf MJ, Khademi B, Ghaderi A, Erfani N, Razmkhah M. Chemokine and chemokine receptor patterns in patients with benign and malignant salivary gland tumors: a distinct role for CCR7. European cytokine network. 2017;28(1):27-35.

13.          Haghshenas MR, Dabbaghmanesh MH, Miri A, Ghaderi A, Erfani N. Association of PDCD1 gene markers with susceptibility to thyroid cancer. Journal of endocrinological investigation. 2017;40(5):481-6.

14.          Khaghanzadeh N, Samiei A, Mojtahedi Z, Ramezani M, Hosseinzadeh M, Ghaderi A. Umbelliprenin induced both anti-inflammatory and regulatory cytokines in C57/BL6 mice. Iranian journal of basic medical sciences. 2017;20(7):829-34.

15.          Malek-Hosseini Z, Jelodar S, Talei A, Ghaderi A, Doroudchi M. Elevated Syndecan-1 levels in the sera of patients with breast cancer correlate with tumor size. Breast cancer (Tokyo, Japan). 2017;24(6):742-7.

16.          Menezes J, Edraki N, Kamat SP, Khoshneviszadeh M, Kayani Z, Mirzaei HH, et al. Long Chain Alkyl Esters of Hydroxycinnamic Acids as Promising Anticancer Agents: Selective Induction of Apoptosis in Cancer Cells. Journal of agricultural and food chemistry. 2017;65(33):7228-39.

17.          Namavar Jahromi F, Samadi M, Mojtahedi Z, Haghshenas MR, Taghipour M, Erfani N. Association of PD-1.5 C/T, but Not PD-1.3 G/A, with Malignant and Benign Brain Tumors in Iranian Patients. Immunological investigations. 2017;46(5):469-80.

18.          Negahdaripour M, Eslami M, Nezafat N, Hajighahramani N, Ghoshoon MB, Shoolian E, et al. A novel HPV prophylactic peptide vaccine, designed by immunoinformatics and structural vaccinology approaches. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases. 2017;54:402-16.

19.          Ramezani A, Mahmoudi Maymand E, Yazdanpanah-Samani M, Hosseini A, Toghraie FS, Ghaderi A. Improving Pertuzumab production by gene optimization and proper signal peptide selection. Protein expression and purification. 2017;135:24-32.

20.          Rezaei M, Ghaderi A. Production of a Mouse Monoclonal Antibody Against Mortalin by Whole Cell Immunization. Monoclonal antibodies in immunodiagnosis and immunotherapy. 2017;36(4):169-75.

21.          Rezaei M, Hosseini A, Nikeghbalian S, Ghaderi A. Establishment and characterization of a new human acinar cell carcinoma cell line, Faraz-ICR, from pancreas. Pancreatology : official journal of the International Association of Pancreatology (IAP)  [et al]. 2017;17(2):303-9.

22.          Shahriari S, Rezaeifard S, Moghimi HR, Khorramizadeh MR, Faghih Z. Cell membrane and intracellular expression of toll-like receptor 9 (TLR9) in colorectal cancer and breast cancer cell-lines. Cancer biomarkers : section A of Disease markers. 2017;18(4):375-80.

23.          Shamsdin SA, Alborzi A, Rasouli M, Ghaderi A, Lankrani KB, Dehghani SM, et al. The importance of TH22 and TC22 cells in the pathogenesis of Helicobacter pylori-associated gastric diseases. Helicobacter. 2017;22(3).

24.          Taghipour M, Omidvar A, Razmkhah M, Ghaderi A, Mojtahedi Z. Comparative Proteomic Analysis of Tumor Mesenchymal-Like Stem Cells Derived from High Grade versus Low Grade Gliomas. Cell journal. 2017;19(2):250-8.

25.          Toghraie FS, Sharifzadeh SM, Ramezani A, Mahmoudi Maymand E, Yazdanpanah-Samani M, Ghaderi A. Cloning and Expression of Recombinant Human Interleukin-7 in Chinese Hamster Ovary (CHO) Cells. Reports of biochemistry & molecular biology. 2017;6(1):66-73.

 

2016
 

1.            Ashouri E, Norman PJ, Guethlein LA, Han AS, Nemat-Gorgani N, Norberg SJ, et al. HLA class I variation in Iranian Lur and Kurd populations: high haplotype and allotype diversity with an abundance of KIR ligands. Hla. 2016;88(3):87-99.

2.            Ayatollahi M, Talaei-Khozani T, Razmkhah M. Growth suppression effect of human mesenchymal stem cells from bone marrow, adipose tissue, and Wharton's jelly of umbilical cord on PBMCs. Iranian journal of basic medical sciences. 2016;19(2):145-53.

3.            Bahramali E, Firouzabadi N, Yavarian I, Shayesteh MR, Erfani N, Shoushtari AA, et al. Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial. European journal of clinical pharmacology. 2016;72(9):1059-64.

4.            Bolourian A, Mojtahedi Z. Monitoring of CD8(+) T-cell Activity in mTOR Inhibitor-treated Cancer Patients for Successful Immunotherapy. Archives of medical research. 2016;47(5):401-2.

5.            Faghihi SA, Khankeh HR, Hosseini SJ, Soltani Arabshahi SK, Faghih Z, Parikh SV, et al. Improving continuing medical education by enhancing interactivity: lessons from Iran. Journal of advances in medical education & professionalism. 2016;4(2):54-63.

6.            Faraji A, Abtahi S, Ghaderi A, Samsami Dehaghani A. Transforming Growth Factor beta1 (TGF-beta1) in the Sera of Postmenopausal Osteoporotic Females. International journal of endocrinology and metabolism. 2016;14(4):e36511.

7.            Fazel Anvari-Yazdi A, Tahermanesh K, Hadavi SM, Talaei-Khozani T, Razmkhah M, Abed SM, et al. Cytotoxicity assessment of adipose-derived mesenchymal stem cells on synthesized biodegradable Mg-Zn-Ca alloys. Materials science & engineering C, Materials for biological applications. 2016;69:584-97.

8.            Firouzabadi N, Ghazanfari N, Alavi Shoushtari A, Erfani N, Fathi F, Bazrafkan M, et al. Genetic Variants of Angiotensin-Converting Enzyme Are Linked to Autism: A Case-Control Study. PloS one. 2016;11(4):e0153667.

9.            Haghshenas MR, Khademi B, Ashraf MJ, Ghaderi A, Erfani N. Helper and cytotoxic T-cell subsets (Th1, Th2, Tc1, and Tc2) in benign and malignant salivary gland tumors. Oral diseases. 2016;22(6):566-72.

10.          Jafarinia M, Mehdipour F, Hosseini SV, Ghahramani L, Hosseinzadeh M, Ghaderi A. Determination of a CD4(+)CD25(-)FoxP3(+) T cells subset in tumor-draining lymph nodes of colorectal cancer secreting IL-2 and IFN-gamma. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2016;37(11):14659-66.

11.          Jafarzadeh A, Fooladseresht H, Nemati M, Assadollahi Z, Sheikhi A, Ghaderi A. Higher circulating levels of chemokine CXCL10 in patients with breast cancer: Evaluation of the influences of tumor stage and chemokine gene polymorphism. Cancer biomarkers : section A of Disease markers. 2016;16(4):545-54.

12.          Khaghanzadeh N, Nakamura K, Kuramitsu Y, Ghaderi A, Mojtahedi Z. Immune-associated proteins with potential in vivo anti-tumor activities are upregulated in lung cancer cells treated with umbelliprenin: A proteomic approach. Oncology letters. 2016;12(6):5295-302.

13.          Mehdipour F, Razmkhah M, Hosseini A, Bagheri M, Safaei A, Talei AR, et al. Increased B Regulatory Phenotype in Non-Metastatic Lymph Nodes of Node-Positive Breast Cancer Patients. Scandinavian journal of immunology. 2016;83(3):195-202.

14.          Shahsavani MB, Ahmadi S, Aseman MD, Nabavizadeh SM, Rashidi M, Asadi Z, et al. Anticancer activity assessment of two novel binuclear platinum (II) complexes. Journal of photochemistry and photobiology B, Biology. 2016;161:345-54.

15.          Shegefti MS, Malekzadeh M, Malek-Hosseini Z, Khademi B, Ghaderi A, Doroudchi M. Reduced serum levels of syndecan-1 in patients with tongue squamous cell carcinoma. The Laryngoscope. 2016;126(5):E191-5.

17.          Tati K, Yazdanpanah-Samani M, Ramezani A, Mahmoudi Maymand E, Ghaderi A. Establishment a CHO Cell Line Expressing Human CD52 Molecule. Reports of biochemistry & molecular biology. 2016;5(1):56-61.

18.          Yadegari ZS, Akrami H, Hosseini SV, Erfani N. miR-146a gene polymorphism and susceptibility to gastric cancer. British journal of biomedical science. 2016;73(4):201-3.

19.          Yazdani Y, Sharifi Rad MR, Taghipour M, Chenari N, Ghaderi A, Razmkhah M. Genistein Suppression of Matrix Metalloproteinase 2 (MMP-2) and Vascular Endothelial Growth Factor (VEGF) Expression in Mesenchymal Stem Cell Like Cells Isolated from High and Low Grade Gliomas. Asian Pacific journal of cancer prevention : APJCP. 2016;17(12):5303-7.

 

2015

1.         Sanaee MN, Malekzadeh M, Khezri A, Ghaderi A, Doroudchi M. Soluble CD138/Syndecan-1 Increases in the Sera of Patients with Moderately Differentiated Bladder Cancer. Urologia internationalis. 2015;94(4):472-8.

2. Rezaeifard S, Razmkhah M, Robati M, Momtahan M, Ghaderi A. Cytokines, chemokines, and chemokine receptors quantitative expressions in patients with ovarian cancer. Iranian journal of medical sciences. 2015;40(3):225-32.

3.         Razmkhah M, Abedi N, Hosseini A, Imani MT, Talei AR, Ghaderi A. Induction of T Regulatory Subsets from Naive CD4+ T Cells after Exposure to Breast Cancer Adipose Derived Stem Cells. Iranian journal of immunology : IJI. 2015;12(1):1-15.

4.         Nemati K, Golmoghaddam H, Hosseini SV, Ghaderi A, Doroudchi M. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression. Gene. 2015;561(1):88-94.

5.         Namazi S, Sahebi E, Rostami-Yalmeh J, Jaberipour M, Razmkhah M, Hosseini A, et al. Effect of angiotensin receptor blockade on prevention and reversion of tamoxifen-resistant phenotype in MCF-7 cells. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine. 2015;36(2):893-900.

6.            Rezaeifard S, Razmkhah M, Robati M, et al. Cytokines, chemokines, and chemokine receptors quantitative expressions in patients with ovarian cancer. Iranian journal of medical sciences. 2015;40(3):225-232.

7.            Razmkhah M, Abedi N, Hosseini A, et al. Induction of T Regulatory Subsets from Naive CD4+ T Cells after Exposure to Breast Cancer Adipose Derived Stem Cells. Iranian journal of immunology : IJI. 2015;12(1):1-15.

8.            Omidvari S, Zohourinia S, Ansari M, et al. Efficacy and Safety of Low-Dose-Rate Endorectal Brachytherapy as a Boost to Neoadjuvant Chemoradiation in the Treatment of Locally Advanced Distal Rectal Cancer: A Phase-II Clinical Trial. Annals of coloproctology. 2015;31(4):123-130.

9.            Nemati K, Golmoghaddam H, Hosseini SV, et al. Interleukin-17FT7488 allele is associated with a decreased risk of colorectal cancer and tumor progression. Gene. 2015;561(1):88-94.

10.            Khosravi-Maharlooei M, Jaberipour M, Hosseini Tashnizi A, et al. Expression Pattern of Alternative Splicing Variants of Human Telomerase Reverse Transcriptase (hTERT) in Cancer Cell Lines Was not Associated with the Origin of the Cells. International journal of molecular and cellular medicine. 2015;4(2):109-119.

11.            Khodadad M, Hosseini SY, Shenavar F, et al. Construction of expressing vectors including melanoma differentiation-associated gene-7 (mda-7) fused with the RGD sequences for better tumor targeting. Iranian journal of basic medical sciences. 2015;18(8):780-787.

12.            Haghshenas MR, Khademi B, Faghih Z, et al. Immune regulatory cells and IL17-producing lymphocytes in patients with benign and malignant salivary gland tumors. Immunology letters. 2015;164(2):109-116.

13.            Golestan AM, Mojtahedi ZP, Ghalamfarsa GP, et al. The Effects of NDRG2 Overexpression on Cell Proliferation and Invasiveness of SW48 Colorectal Cancer Cell Line. Iranian journal of medical sciences. 2015;40(5):430-439.

14.            Fazelzadeh Haghighi M, Ali Ghayumi M, Behzadnia F, et al. Investigation of FOXP3 genetic variations at positions -2383 C/T and IVS9+459 T/C in southern Iranian patients with lung carcinoma. Iranian journal of basic medical sciences. 2015;18(5):465-471.

15.          Faraji SN, Mojtahedi Z, Ghalamfarsa G, et al. N-myc downstream regulated gene 2 overexpression reduces matrix metalloproteinase-2 and -9 activities and cell invasion of A549 lung cancer cell line in vitro. Iranian journal of basic medical sciences. 2015;18(8):773-779.

16.          Erfani N, Nazemosadat Z, Moein M. Cytotoxic activity of ten algae from the Persian Gulf and Oman Sea on human breast cancer cell lines; MDA-MB-231, MCF-7, and T-47D. Pharmacognosy research. 2015;7(2):133-137.

17.          Baharlou R, Khezri A, Razmkhah M, et al. Increased interleukin-17 transcripts in peripheral blood mononuclear cells, a link between T-helper 17 and proinflammatory responses in bladder cancer. Iranian Red Crescent medical journal. 2015;17(2):e9244.

 

2014

 

1.            Ziaian B, Saberi A, Ghayyoumi MA, Safaei A, Ghaderi A, Mojtahedi Z. Association of high LDH and low glucose levels in pleural space with HER2 expression in non-small cell lung cancer. Asian Pacific journal of cancer prevention : APJCP. 2014;15(4):1617-20.

2.            Taghipour Fard Ardekani M, Malekzadeh M, Hosseini SV, Bordbar E, Doroudchi M, Ghaderi A. Evaluation of Pre-Treatment Serum Levels of IL-7 and GM-CSF in Colorectal Cancer Patients. International journal of molecular and cellular medicine. 2014;3(1):27-34.

3.            Sarvari J, Mojtahedi Z, Kuramitsu Y, Fattahi MR, Ghaderi A, Nakamura K, et al. Comparative Proteomics of Sera From HCC Patients With Different Origins. Hepatitis monthly. 2014;14(1):e13103.

4.            Sanaee MN, Malekzadeh M, Khezri A, Ghaderi A, Doroudchi M. Soluble CD138/Syndecan-1 Increases in the Sera of Patients with Moderately Differentiated Bladder Cancer. Urologia internationalis. 2014.

5.            Rezaeifard S, Razmkhah M, Robati M, Momtahan M, Ghaderi A. Adipose derived stem cells isolated from omentum: a novel source of chemokines for ovarian cancer growth. Journal of cancer research and therapeutics. 2014;10(1):159-64.

6.            Razmkhah M, Jaberipour M, Ghaderi A. Downregulation of MMP2 and Bcl-2 in Adipose Derived Stem Cells (ASCs) following Transfection with IP-10 Gene. Avicenna journal of medical biotechnology. 2014;6(1):27-37.

7.            Razmkhah M, Habibagahi M, Alizadeh F, Hosseini A, Ghaderi A, Searle PF, et al. Synergistic anti-tumor effects of nitroreductase mutants and p53. Journal of cancer research and therapeutics. 2014;10(3):665-70.

8.            Razmkhah M, Arabpour F, Taghipour M, Mehrafshan A, Chenari N, Ghaderi A. Expression of chemokines and chemokine receptors in brain tumor tissue derived cells. Asian Pacific journal of cancer prevention : APJCP. 2014;15(17):7201-5.

9.            Mojtahedi Z, Khademi B, Erfani N, Taregh Y, Rafati Z, Malekzadeh M, et al. Serum levels of interleukin-7 and interleukin-8 in head and neck squamous cell carcinoma. Indian journal of cancer. 2014;51(3):227-30.

10.          Khodadadi A, Razmkhah M, Eskandari AR, Hosseini A, Habibagahi M, Ghaderi A, et al. IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer. Iranian journal of medical sciences. 2014;39(4):350-6.

11.          Khaghanzadeh N, Samiei A, Ramezani M, Mojtahedi Z, Hosseinzadeh M, Ghaderi A. Umbelliprenin induced production of IFN-gamma and TNF-alpha, and reduced IL-10, IL-4, Foxp3 and TGF-beta in a mouse model of lung cancer. Immunopharmacology and immunotoxicology. 2014;36(1):25-32.

12.          Khademi B, Soleimanpour M, Ghaderi A, Mohammadianpanah M. Prognostic and predictive value of serum vascular endothelial growth factor (VEGF) in squamous cell carcinoma of the head and neck. Oral and maxillofacial surgery. 2014;18(2):187-96.

13.          Ghaderi H, Kiany F, Razmkhah M, Dadras S, Chenari N, Hosseini A, et al. mRNA expression of pattern recognition receptors and their signaling mediators in healthy and diseased gingival tissues. Journal of Indian Society of Periodontology. 2014;18(2):150-4.

14.          Faghih Z, Erfani N, Haghshenas MR, Safaei A, Talei AR, Ghaderi A. Immune profiles of CD4+ lymphocyte subsets in breast cancer tumor draining lymph nodes. Immunology letters. 2014;158(1-2):57-65.

2013

15.          Sarvari J, Mojtahedi Z, Taghavi SA, Kuramitsu Y, Shamsi Shahrabadi M, Ghaderi A, et al. Differentially Expressed Proteins in Chronic Active Hepatitis, Cirrhosis, and HCC Related to HCV Infection in Comparison With HBV Infection: A proteomics study. Hepatitis monthly. 2013;13(7):e8351.

16.          Salimzadeh L, Jaberipour M, Hosseini A, Ghaderi A. Non-viral transfection methods optimized for gene delivery to a lung cancer cell line. Avicenna journal of medical biotechnology. 2013;5(2):68-77.

17.          Robati M, Ghaderi A, Mehraban M, Shafizad A, Nasrolahi H, Mohammadianpanah M. Vascular endothelial growth factor (VEGF) improves the sensitivity of CA125 for differentiation of epithelial ovarian cancers from ovarian cysts. Archives of gynecology and obstetrics. 2013;288(4):859-65.

18.          Razmkhah M, Ghaderi A. SDF-1alpha G801A polymorphism in Southern Iranian patients with colorectal and gastric cancers. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology. 2013;32(1):28-31.

19.          Razmkhah M, Ghaderi A. HLA Class I Allele Frequencies in Southern Iranian Women with Breast Cancer. Iranian journal of basic medical sciences. 2013;16(2):140-3.

20.          Mojtahedi Z, Erfani N, Malekzadeh M, Haghshenas MR, Ghaderi A, Samsami Dehaghani A. HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer. Iranian Red Crescent medical journal. 2013;15(1):1-3.

21.          Malekzadeh M, Dehaghani AS, Ghaderi A, Doroudchi M. IL-17A is elevated in sera of patients with poorly differentiated ovarian papillary serous cystadenocarcinoma. Cancer biomarkers : section A of Disease markers. 2013;13(6):417-25.

22.          Khademi B, Ghaderi A, Hosseini SF, Niknejad N. Early Detection of Serum Levels of HER-2 in Patients with Head and Neck Squamous Cell Carcinoma. Iranian journal of otorhinolaryngology. 2013;25(72):161-8.

23.          Hooshmand S, Ghaderi A, Yusoff K, Karrupiah T, Rosli R, Mojtahedi Z. Downregulation of RhoGDIalpha increased migration and invasion of ER (+) MCF7 and ER (-) MDA-MB-231 breast cancer cells. Cell adhesion & migration. 2013;7(3):297-303.

24.          Habibagahi M, Razmkhah M, Niri NM, Hosseini A, Ghaderi A, Jaberipour M. Combined 4-1BB and CD28 costimulation could unleash lymphocytes from immunosuppression induced by adipose derived stem cell soluble products. Immunological investigations. 2013;42(4):307-23.

25.          Golmoghaddam H, Arandi N, Ghaderi A, Doroudchi M. Polymorphism in Exon 2 of CD1 Genes in Southwest of Iran. Iranian journal of public health. 2013;42(7):775-82.

26.          Ghiasi N, Habibagahi M, Rosli R, Ghaderi A, Yusoff K, Hosseini A, et al. Tumour suppressive effects of WEE1 gene silencing in breast cancer cells. Asian Pacific journal of cancer prevention : APJCP. 2013;14(11):6605-11.

27.          Faghih Z, Rezaeifard S, Safaei A, Ghaderi A, Erfani N. IL-17 and IL-4 producing CD8+ T cells in tumor draining lymph nodes of breast cancer patients: positive association with tumor progression. Iranian journal of immunology : IJI. 2013;10(4):193-204.

28.          Erfani N, Khademi B, Haghshenas MR, Mojtahedi Z, Ghaderi A. Intracellular CTLA4 and regulatory T cells in patients with laryngeal squamous cell carcinoma. Immunological investigations. 2013;42(2):81-90.

29.          Doroudchi M, Saidi M, Malekzadeh M, Golmoghaddam H, Khezri A, Ghaderi A. Elevated IL-17A levels in early stages of bladder cancer regardless of smoking status. Future oncology (London, England). 2013;9(2):295-304.

30.          Doroudchi M, Pishe ZG, Malekzadeh M, Golmoghaddam H, Taghipour M, Ghaderi A. Elevated serum IL-17A but not IL-6 in glioma versus meningioma and schwannoma. Asian Pacific journal of cancer prevention : APJCP. 2013;14(9):5225-30.

2012

31.          Yousefi Z, Sarvari J, Nakamura K, Kuramitsu Y, Ghaderi A, Mojtahedi Z. Secretomic analysis of large cell lung cancer cell lines using two-dimensional gel electrophoresis coupled to mass spectrometry. Folia histochemica et cytobiologica / Polish Academy of Sciences, Polish Histochemical and Cytochemical Society. 2012;50(3):368-74.

32.          Toghraie F, Razmkhah M, Gholipour MA, Faghih Z, Chenari N, Torabi Nezhad S, et al. Scaffold-free adipose-derived stem cells (ASCs) improve experimentally induced osteoarthritis in rabbits. Archives of Iranian medicine. 2012;15(8):495-9.

33.          Razmkhah M, Jaberipour M, Safaei A, Talei AR, Erfani N, Ghaderi A. Chemokine and chemokine receptors: a comparative study between metastatic and nonmetastatic lymph nodes in breast cancer patients. European cytokine network. 2012;23(3):72-7.

34.          Noori S, Monabati A, Ghaderi A. The prevalence of human papilloma virus in esophageal squamous cell carcinoma. Iranian journal of medical sciences. 2012;37(2):126-33.

35.          Motamedifar M, Saki M, Ghaderi A. Lack of association of mouse mammary tumor virus-like sequences in Iranian breast cancer patients. Medical principles and practice : international journal of the Kuwait University, Health Science Centre. 2012;21(3):244-8.

36.          Mojtahedi Z, Mohmedi M, Rahimifar S, Erfani N, Hosseini SV, Ghaderi A. Programmed death-1 gene polymorphism (PD-1.5 C/T) is associated with colon cancer. Gene. 2012;508(2):229-32.

37.          Mojtahedi Z, Khademi B, Yehya A, Talebi A, Fattahi MJ, Ghaderi A. Serum levels of interleukins 4 and 10 in head and neck squamous cell carcinoma. The Journal of laryngology and otology. 2012;126(2):175-9.

38.          Khaghanzadeh N, Mojtahedi Z, Ramezani M, Erfani N, Ghaderi A. Umbelliprenin is cytotoxic against QU-DB large cell lung cancer cell line but anti-proliferative against A549 adenocarcinoma cells. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences. 2012;20(1):69.

39.          Khademi B, Hashemi SB, Ghaderi A, Shahrestani A, Mohammadianpanah M. Interleukin-13 gene polymorphisms at -1055 C/T and +2044 G/A positions in patients with squamous cell carcinoma of head and neck. Brazilian journal of otorhinolaryngology. 2012;78(5):64-8.

40.          Erfani N, Moghaddasi-Sani F, Razmkhah M, Haghshenas MR, Talei A, Ghaderi A. CCL22 16C/a genetic variation is not associated with breast carcinoma in Southern Iranian population. Iranian journal of immunology : IJI. 2012;9(4):226-33.

41.          Erfani N, Mehrabadi SM, Ghayumi MA, Haghshenas MR, Mojtahedi Z, Ghaderi A, et al. Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC). Lung cancer (Amsterdam, Netherlands). 2012;77(2):306-11.

42.          Erfani N, Haghshenas MR, Hoseini MA, Hashemi SB, Khademi B, Ghaderi A. Strong association of CTLA-4 variation (CT60A/G) and CTLA-4 haplotypes with predisposition of Iranians to head and neck cancer. Iranian journal of immunology : IJI. 2012;9(3):188-98.

43.          Bordbar E, Malekzadeh M, Ardekani MT, Doroudchi M, Ghaderi A. Serum levels of G-CSF and IL-7 in Iranian breast cancer patients. Asian Pacific journal of cancer prevention : APJCP. 2012;13(10):5307-12.

44.          Bahrani H, Razmkhah M, Ashraf MJ, Tanideh N, Chenari N, Khademi B, et al. Differentiation of adipose-derived stem cells into ear auricle cartilage in rabbits. The Journal of laryngology and otology. 2012;126(8):770-4.

45.          Ashouri E, Dabbaghmanesh MH, Rowhanirad S, Bakhshayeshkaram M, Ranjbar Omrani G, Ghaderi A. Activating KIR2DS5 receptor is a risk for thyroid cancer. Human immunology. 2012;73(10):1017-22.

2011

46.          Toghraie FS, Chenari N, Gholipour MA, Faghih Z, Torabinejad S, Dehghani S, et al. Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in Rabbit. The Knee. 2011;18(2):71-5.

47.          Sarvari J, Mojtahedi Z, Kuramitsu Y, Malek-Hosseini SA, Shamsi Shahrabadi M, Ghaderi A, et al. Differential expression of haptoglobin isoforms in chronic active hepatitis, cirrhosis and HCC related to HBV infection. Oncology letters. 2011;2(5):871-7.

48.          Razmkhah M, Jaberipour M, Ghaderi A. Bcl-2 and Fas expressions correlate with proliferative specificity of adipose-derived stem cells (ASCs) in breast cancer. Immunological investigations. 2011;40(3):290-8.

49.          Razmkhah M, Jaberipour M, Erfani N, Habibagahi M, Talei AR, Ghaderi A. Adipose derived stem cells (ASCs) isolated from breast cancer tissue express IL-4, IL-10 and TGF-beta1 and upregulate expression of regulatory molecules on T cells: do they protect breast cancer cells from the immune response? Cellular immunology. 2011;266(2):116-22.

50.          Mojtahedi Z, Safaei A, Yousefi Z, Ghaderi A. Immunoproteomics of HER2-positive and HER2-negative breast cancer patients with positive lymph nodes. Omics : a journal of integrative biology. 2011;15(6):409-18.

51.          Mojtahedi Z, Khademi B, Hashemi SB, Abtahi SM, Ghasemi MA, Fattahi MJ, et al. Serum interleukine-6 concentration, but not interleukine-18, is associated with head and neck squamous cell carcinoma progression. Pathology oncology research : POR. 2011;17(1):7-10.

52.          Jaberipour M, Samsami A, Sahraiian F, Kazerooni T, Hashemi M, Ghaderi A, et al. Elevation of HPV-18 and HPV-16 DNA in the plasma of patients with advanced cervical cancer. Asian Pacific journal of cancer prevention : APJCP. 2011;12(1):163-7.

53.          Jaberipour M, Momtahan M, Najib F, Amooei S, Saidifard F, Ghaderi A, et al. Detection of high-risk human papillomavirus types 16 and 18 but not 33 and 52 in external genital warts from Iranian females. Asian Pacific journal of cancer prevention : APJCP. 2011;12(3):771-4.

54.          Haghshenas MR, Naeimi S, Talei A, Ghaderi A, Erfani N. Program death 1 (PD1) haplotyping in patients with breast carcinoma. Molecular biology reports. 2011;38(6):4205-10.

55.          Golmoghaddam H, Pezeshki AM, Ghaderi A, Doroudchi M. CD1a and CD1d genes polymorphisms in breast, colorectal and lung cancers. Pathology oncology research : POR. 2011;17(3):669-75.

56.          Ghaderi A. CTLA4 gene variants in autoimmunity and cancer: a comparative review. Iranian journal of immunology : IJI. 2011;8(3):127-49.

57.          Firouzabadi H, Iranpoor N, Ghaderi A. Gelatin as a bioorganic reductant, ligand and support for palladium nanoparticles. Application as a catalyst for ligand- and amine-free Sonogashira-Hagihara reaction. Organic & biomolecular chemistry. 2011;9(3):865-71.

58.          Farjadian S, Sazzini M, Tofanelli S, Castri L, Taglioli L, Pettener D, et al. Discordant patterns of mtDNA and ethno-linguistic variation in 14 Iranian Ethnic groups. Human heredity. 2011;72(2):73-84.

2010

59.          Razmkhah M, Jaberipour M, Hosseini A, Safaei A, Khalatbari B, Ghaderi A. Expression profile of IL-8 and growth factors in breast cancer cells and adipose-derived stem cells (ASCs) isolated from breast carcinoma. Cellular immunology. 2010;265(1):80-5.

60.          Rahimifar S, Erfani N, Sarraf Z, Ghaderi A. ctla-4 gene variations may influence cervical cancer susceptibility. Gynecologic oncology. 2010;119(1):136-9.

61.          Mojtahedi Z, Hashemi SB, Khademi B, Karimi M, Haghshenas MR, Fattahi MJ, et al. p53 codon 72 polymorphism association with head and neck squamous cell carcinoma. Brazilian journal of otorhinolaryngology. 2010;76(3):316-20.

62.          Mojtahedi Z, Haghshenas MR, Hosseini SV, Fattahi MJ, Ghaderi A. p 53 codon 72 polymorphism in stomach and colorectal adenocarcinomas in Iranian patients. Indian journal of cancer. 2010;47(1):31-4.

63.          Mahjour SB, Ghaffarpasand F, Fattahi MJ, Ghaderi A, Fotouhi Ghiam A, Karimi M. Seroprevalence of human herpes simplex, hepatitis B and epstein-barr viruses in children with acute lymphoblastic leukemia in southern iran. Pathology oncology research : POR. 2010;16(4):579-82.

64.          Khaghanzadeh N, Erfani N, Ghayumi MA, Ghaderi A. CTLA4 gene variations and haplotypes in patients with lung cancer. Cancer genetics and cytogenetics. 2010;196(2):171-4.

65.          Jaberipour M, Habibagahi M, Hosseini A, Habibabad SR, Talei A, Ghaderi A. Increased CTLA-4 and FOXP3 transcripts in peripheral blood mononuclear cells of patients with breast cancer. Pathology oncology research : POR. 2010;16(4):547-51.

66.          Jaberipour M, Habibagahi M, Hosseini A, Abbasi M, Sobhani-Lari A, Talei A, et al. Detection of B cell lymphoma 2, tumor protein 53, and FAS gene transcripts in blood cells of patients with breast cancer. Indian journal of cancer. 2010;47(4):412-7.

67.          Erfani N, Razmkhah M, Ghaderi A. Circulating soluble CTLA4 (sCTLA4) is elevated in patients with breast cancer. Cancer investigation. 2010;28(8):828-32.

68.          Dehaghani AS, Zamanpour T, Naeimi S, Sameni S, Robati M, Ghaderi A. Genetic variation in TGF-beta 1 gene promoter and risk of gestational trophoblastic disease. The Journal of reproductive medicine. 2010;55(3-4):151-6.

2009

69.          Yousefipour G, Erfani N, Momtahan M, Moghaddasi H, Ghaderi A. CTLA4 exon 1 and promoter polymorphisms in patients with multiple sclerosis. Acta neurologica Scandinavica. 2009;120(6):424-9.

70.          Vasei M, Modjtahedi H, Ale-Booyeh O, Mosallaei A, Kajbafzadeh AM, Shahriari M, et al. Amplification and expression of EGFR and ERBB2 in Wilms tumor. Cancer genetics and cytogenetics. 2009;194(2):88-95.

71.          Varamini P, Soltani M, Ghaderi A. Cell cycle analysis and cytotoxic potential of Ruta graveolens against human tumor cell lines. Neoplasma. 2009;56(6):490-3.

72.          Varamini P, Javidnia K, Soltani M, Mehdipour AR, Ghaderi A. Cytotoxic activity and cell cycle analysis of quinoline alkaloids isolated from Haplophyllum canaliculatum Boiss. Planta medica. 2009;75(14):1509-16.

73.          Senemar S, Doroudchi M, Pezeshki AM, Bazrgar M, Torab-Jahromi A, Ghaderi A. Frequency of cystathionine beta-synthase 844INS68 polymorphism in Southern Iran. Molecular biology reports. 2009;36(2):353-6.

74.          Samsami Dehaghani A, Shahriary K, Kashef MA, Naeimi S, Fattahi MJ, Mojtahedi Z, et al. Interleukin-18 gene promoter and serum level in women with ovarian cancer. Molecular biology reports. 2009;36(8):2393-7.

75.          Sameni S, Ghayumi MA, Mortazavi G, Faghih Z, Kashef MA, Ghaderi A. Lack of association between interleukin-13 gene polymorphisms (-1055 C/T and +2044 G/A) in Iranian patients with lung cancer. Molecular biology reports. 2009;36(5):1001-5.

76.          Rezaei Z, Firouzabadi H, Iranpoor N, Ghaderi A, Jafari MR, Jafari AA, et al. Design and one-pot synthesis of alpha-aminophosphonates and bis(alpha-aminophosphonates) by iron(III) chloride and cytotoxic activity. European journal of medicinal chemistry. 2009;44(11):4266-75.

77.          Mousavi Niri N, Jaberipour M, Razmkhah M, Ghaderi A, Habibagahi M. Mesenchymal stem cells do not suppress lymphoblastic leukemic cell line proliferation. Iranian journal of immunology : IJI. 2009;6(4):186-94.

78.          Khalili-Azad T, Razmkhah M, Ghiam AF, Doroudchi M, Talei AR, Mojtahedi Z, et al. Association of interleukin-18 gene promoter polymorphisms with breast cancer. Neoplasma. 2009;56(1):22-5.

79.          Haghshenas MR, Hosseini SV, Mahmoudi M, Saberi-Firozi M, Farjadian S, Ghaderi A. IL-18 serum level and IL-18 promoter gene polymorphism in Iranian patients with gastrointestinal cancers. Journal of gastroenterology and hepatology. 2009;24(6):1119-22.

80.          Fattahi MJ, Mojtahedi Z, Karimaghaee N, Talei AR, Banani SJ, Ghaderi A. Analysis of BRCA1 and BRCA2 mutations in southern Iranian Breast cancer patients. Archives of Iranian medicine. 2009;12(6):584-7.

81.          Farjadian S, Ota M, Inoko H, Ghaderi A. The genetic relationship among Iranian ethnic groups: an anthropological view based on HLA class II gene polymorphism. Molecular biology reports. 2009;36(7):1943-50.

82.          Farjadfar A, Mojtahedi Z, Ghayumi MA, Erfani N, Haghshenas MR, Ghaderi A. Interleukin-18 promoter polymorphism is associated with lung cancer: a case-control study. Acta oncologica (Stockholm, Sweden). 2009;48(7):971-6.

83.          Faghih Z, Erfani N, Razmkhah M, Sameni S, Talei A, Ghaderi A. Interleukin13 haplotypes and susceptibility of Iranian women to breast cancer. Molecular biology reports. 2009;36(7):1923-8.

84.          Dehaghani AS, Rad NR, Fattahi MJ, Khadang B, Kashef MA, Sarraf Z, et al. Investigation of soluble HER2 and transforming growth factor Beta-1 serum levels in gestational trophoblastic disease. Pathology oncology research : POR. 2009;15(1):37-40.

85.          Dehaghani AS, Kashef MA, Ghaemenia M, Sarraf Z, Khaghanzadeh N, Fattahi MJ, et al. PDCD1, CTLA-4 and p53 gene polymorphism and susceptibility to gestational trophoblastic diseases. The Journal of reproductive medicine. 2009;54(1):25-31.

86.          Borhani Haghighi A, Ittehadi H, Nikseresht AR, Rahmati J, Poorjahromi SG, Pourabbas B, et al. CSF levels of cytokines in neuro-Behcet's disease. Clinical neurology and neurosurgery. 2009;111(6):507-10.

87.          Amirghofran Z, Jalali SA, Ghaderi A, Hosseini SV. Genetic polymorphism in the transforming growth factor beta1 gene (-509 C/T and -800 G/A) and colorectal cancer. Cancer genetics and cytogenetics. 2009;190(1):21-5.

88.          Alborzi S, Tavazoo F, Dehaghani AS, Ghaderi A, Alborzi M. Determination of antiovarian antibodies after laparoscopic ovarian electrocauterization in patients with polycystic ovary syndrome. Fertility and sterility. 2009;91(4):1159-63.

2008

89.          Tamizifar B, Lankarani KB, Naeimi S, Rismankar Zadeh M, Taghavi A, Ghaderi A. Promoter polymorphism of transforming growth factor-beta1 gene and ulcerative colitis. World journal of gastroenterology : WJG. 2008;14(2):243-7.

90.          Khademi B, Razmkhah M, Erfani N, Gharagozloo M, Ghaderi A. SDF-1 and CCR5 genes polymorphism in patients with head and neck cancer. Pathology oncology research : POR. 2008;14(1):45-50.

91.          Kashef MA, Dehaghani AS, Naeimi S, Fattahi MJ, Ghaderi A. Interleukin-18 gene promoter polymorphisms in women with gestational trophoblastic diseases. The Journal of reproductive medicine. 2008;53(11):853-9.

92.          Farjadian S, Lotfazar M, Ghaderi A. Analysis of human leukocyte antigen class II gene polymorphism in Iranian patients with Papillon-Lefevre syndrome: a family study. Iranian journal of immunology : IJI. 2008;5(3):171-6.

93.          Emamghoreishi M, Bokaee HR, Keshavarz M, Ghaderi A, Tyndale RF. CYP2A6 allele frequencies in an Iranian population. Archives of Iranian medicine. 2008;11(6):613-7.

94.          Arandi N, Talei A, Erfani N, Ghaderi A. Intercellular adhesion molecule-1 genetic markers (+241G/A and +469A/G) in Iranian women with breast cancer. Cancer genetics and cytogenetics. 2008;183(1):9-13.

95.          Amirghofran Z, Jalali SA, Hosseini SV, Vasei M, Sabayan B, Ghaderi A. Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: soluble forms in relation to tumor tissue expression and metastasis. Journal of gastrointestinal cancer. 2008;39(1-4):73-8.

2007

96.          Tamizifar B, Bagheri-Lankarani K, Naeemi S, Rismankar-Zadeh M, Taghavi A, Ghaderi A. Polymorphism of the promoter region of C-509T of transforming growth factor-beta1 gene and ulcerative colitis. Archives of Iranian medicine. 2007;10(2):171-5.

97.          Sharifzadeh S, Modjtahedi H, Jedi Tehrani M, Bayat A, Ghaderi A. Production and characterization of a monoclonal antibody against an antigen on the surface of non-small cell carcinoma of the lung. Iranian journal of immunology : IJI. 2007;4(4):206-14.

98.          Mousavi SA, Nikseresht AR, Arandi N, Borhani Haghighi A, Ghaderi A. Intercellular adhesion molecule-1 gene polymorphism in Iranian patients with multiple sclerosis. European journal of neurology : the official journal of the European Federation of Neurological Societies. 2007;14(12):1397-9.

99.          Khadang B, Fattahi MJ, Talei A, Dehaghani AS, Ghaderi A. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women. Cancer genetics and cytogenetics. 2007;173(1):38-42.

100.        Kashef S, Ghaedian MM, Rajaee A, Ghaderi A. Dyslipoproteinemia during the active course of systemic lupus erythematosus in association with anti-double-stranded DNA (anti-dsDNA) antibodies. Rheumatology international. 2007;27(3):235-41.

101.        Hadinia A, Hossieni SV, Erfani N, Saberi-Firozi M, Fattahi MJ, Ghaderi A. CTLA-4 gene promoter and exon 1 polymorphisms in Iranian patients with gastric and colorectal cancers. Journal of gastroenterology and hepatology. 2007;22(12):2283-7.

102.        Farjadian S, Ghaderi A. HLA class II genetic diversity in Arabs and Jews of Iran. Iranian journal of immunology : IJI. 2007;4(2):85-93.

103.        Farjadian S, Ghaderi A. HLA class II similarities in Iranian Kurds and Azeris. International journal of immunogenetics. 2007;34(6):457-63.

104.        Dehaghani AS, Ghiam AF, Hosseini M, Mansouri S, Ghaderi A. Factors influencing serum concentration of CA125 and CA15-3 in Iranian healthy postmenopausal women. Pathology oncology research : POR. 2007;13(4):360-4.

2006

105.        Rajaee A, Ebrahimi A, Ghiam AF, Kalantari T, Ghaderi A. Exon-1 polymorphism of ctla-4 gene is not associated with systemic sclerosis in Iranian patients. Rheumatology international. 2006;26(8):687-92.

106.        Pezeshki A, Sari-Aslani F, Ghaderi A, Doroudchi M. p53 codon 72 polymorphism in basal cell carcinoma of the skin. Pathology oncology research : POR. 2006;12(1):29-33.

107.        Naeimi S, Ghiam AF, Mojtahedi Z, Dehaghani AS, Amani D, Ghaderi A. Interleukin-18 gene promoter polymorphisms and recurrent spontaneous abortion. European journal of obstetrics, gynecology, and reproductive biology. 2006;128(1-2):5-9.

108.        Mojtahedi Z, Naeimi S, Farjadian S, Omrani GR, Ghaderi A. Association of IL-18 promoter polymorphisms with predisposition to Type 1 diabetes. Diabetic medicine : a journal of the British Diabetic Association. 2006;23(3):235-9.

109.        Mojtahedi Z, Ahmadi SB, Razmkhah M, Azad TK, Rajaee A, Ghaderi A. Association of chemokine receptor 5 (CCR5) delta32 mutation with Behcet's disease is dependent on gender in Iranian patients. Clinical and experimental rheumatology. 2006;24(5 Suppl 42):S91-4.

110.        Lankarani KB, Karbasi A, Kalantari T, Yarmohammadi H, Saberi-Firoozi M, Alizadeh-Naeeni M, et al. Analysis of cytotoxic T lymphocyte associated antigen 4 gene polymorphisms in patients with ulcerative colitis. Journal of gastroenterology and hepatology. 2006;21(2):449-53.

111.        Farjadian S, Moqadam FA, Ghaderi A. HLA class II gene polymorphism in Parsees and Zoroastrians of Iran. International journal of immunogenetics. 2006;33(3):185-91.

112.        Farjadian S, Ghaderi A. Iranian Lurs Genetic Diversity: An Anthropological View Based on HLA Class II Profiles. Iranian journal of immunology : IJI. 2006;3(3):106-13.

113.        Faramarzi A, Shamseddin A, Ghaderi A. IgM, IgG Serum Levels and Lymphocytes Count before and after Adenotonsillectomy. Iranian journal of immunology : IJI. 2006;3(4):187-91.

114.        Erfani N, Razmkhah M, Talei AR, Pezeshki AM, Doroudchi M, Monabati A, et al. Cytotoxic T lymphocyte antigen-4 promoter variants in breast cancer. Cancer genetics and cytogenetics. 2006;165(2):114-20.

115.        Almasi S, Erfani N, Mojtahedi Z, Rajaee A, Ghaderi A. Association of CTLA-4 gene promoter polymorphisms with systemic sclerosis in Iranian population. Genes and immunity. 2006;7(5):401-6.

2005

116.        Samsami Dehaghani A, Doroudchi M, Kalantari T, Pezeshki AM, Ghaderi A. Heterozygosity in CTLA-4 gene and severe preeclampsia. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2005;88(1):19-24.

117.        Razmkhah M, Talei AR, Doroudchi M, Khalili-Azad T, Ghaderi A. Stromal cell-derived factor-1 (SDF-1) alleles and susceptibility to breast carcinoma. Cancer letters. 2005;225(2):261-6.

118.        Razmkhah M, Doroudchi M, Ghayumi SM, Erfani N, Ghaderi A. Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer. Lung cancer (Amsterdam, Netherlands). 2005;49(3):311-5.

119.        Naghibalhossaini F, Pakdel A, Ghaderi AA, Saberi Firoozi M. Effective production of carcinoembryonic antigen by conversion of the membrane-bound into a recombinant secretory protein by site-specific mutagenesis. Pathology oncology research : POR. 2005;11(4):211-7.

120.        Mojtahedi Z, Omrani GR, Doroudchi M, Ghaderi A. CTLA-4 +49 A/G polymorphism is associated with predisposition to type 1 diabetes in Iranians. Diabetes research and clinical practice. 2005;68(2):111-6.

121.        Mojtahedi Z, Ghaderi A. Role of interleukin-18 in allergy and autoimmunity: an explanation for the hygiene hypothesis. Medical hypotheses. 2005;65(2):305-7.

122.        Mojtahedi Z, Farjadian S, Ghaderi A. Does autoantigen administration inhibit recurrence of type 1 diabetes in transplanted islets? Medical hypotheses. 2005;64(5):986-8.

123.        Ghayumi SM, Mehrabi S, Doroudchi M, Ghaderi A. Diagnostic value of tumor markers for differentiating malignant and benign pleural effusions of Iranian patients. Pathology oncology research : POR. 2005;11(4):236-41.

124.        Gharagozloo M, Ghaderi A. Coincident natural selection of CCR5Delta32 and C282Y in Europe: to be or not to be? Journal of genetics. 2005;84(1):47-8.

125.        Gharagozloo M, Doroudchi M, Farjadian S, Pezeshki AM, Ghaderi A. The frequency of CCR5Delta32 and CCR2-64I in southern Iranian normal population. Immunology letters. 2005;96(2):277-81.

2004

126.        Sharifzadeh S, Owji SM, Pezeshki AM, Malek-Hoseini Z, Kumar PV, Ghayumi SM, et al. Establishment and characterization of a human large cell lung cancer cell line with neuroendocrine differentiation. Pathology oncology research : POR. 2004;10(4):225-30.

127.        Ghaderi A, Yeganeh F, Kalantari T, Talei AR, Pezeshki AM, Doroudchi M, et al. Cytotoxic T lymphocyte antigen-4 gene in breast cancer. Breast cancer research and treatment. 2004;86(1):1-7.

128.        Farjadian S, Naruse T, Kawata H, Ghaderi A, Bahram S, Inoko H. Molecular analysis of HLA allele frequencies and haplotypes in Baloch of Iran compared with related populations of Pakistan. Tissue antigens. 2004;64(5):581-7.

129.        Doroudchi M, Dehaghani AS, Ghaderi A. Preferential placental transfer of Helicobacter pylori specific IgG. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2004;16(5):297-301.

130.        Amani D, Zolghadri J, Dehaghani AS, Pezeshki AM, Ghaderi A. The promoter region (-800, -509) polymorphisms of transforming growth factor-beta1 (TGF-beta1) gene and recurrent spontaneous abortion. Journal of reproductive immunology. 2004;62(1-2):159-66.

2003

131.        Samsami Dehaghani A, Doroudchi M, Ghaderi A. Placental transfer of tetanus-specific immunoglobulin G in Iranian mothers. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2003;14(3):147-50.

132.        Kalantari T, Mostafavi H, Pezeshki AM, Farjadian S, Doroudchi M, Yeganeh F, et al. Exon-1 polymorphism of ctla-4 gene in Iranian patients with Graves' disease. Autoimmunity. 2003;36(5):313-6.

133.        Farjadian S, Asadi E, Doroudchi M, Dehaghani AS, Tabei SZ, Kumar VP, et al. High risk HPV types in southern Iranian patients with cervical cancer. Pathology oncology research : POR. 2003;9(2):121-5.

134.        Doroudchi M, Samsami Dehaghani A, Emad K, Ghaderi A. Placental transfer of rubella-specific IgG in fullterm and preterm newborns. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2003;81(2):157-62.

2002

135.        Khademi B, Shirazi FM, Vasei M, Doroudchi M, Gandomi B, Modjtahedi H, et al. The expression of p53, c-erbB-1 and c-erbB-2 molecules and their correlation with prognostic markers in patients with head and neck tumors. Cancer letters. 2002;184(2):223-30.

136.        Kazerooni T, Taallom M, Ghaderi AA. Helicobacter pylori seropositivity in patients with hyperemesis gravidarum. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. 2002;79(3):217-20.

137.        Gharagozloo M, Doroudchi M, Ghaderi A. Effects of Citrus aurantifolia concentrated extract on the spontaneous proliferation of MDA-MB-453 and RPMI-8866 tumor cell lines. Phytomedicine : international journal of phytotherapy and phytopharmacology. 2002;9(5):475-7.

138.        Ghaderi A, Vasei M, Maleck-Hosseini SA, Gharesi-Fard B, Khodami M, Doroudchi M, et al. The expression of c-erbB-1 and c-erbB-2 in Iranian patients with gastric carcinoma. Pathology oncology research : POR. 2002;8(4):252-6.

139.        Dehaghani AS, Amirzargar A, Farjadian S, Ghaderi A. HLA-DQBl alleles and susceptibility to cervical squamous cell carcinoma in Southern Iranian patients. Pathology oncology research : POR. 2002;8(1):58-61.

2001

140.        Pezeshki AM, Farjadian S, Talei A, Vasei M, Gharesi-Fard B, Doroudchi M, et al. p53 gene alteration and protein expression in Iranian women with infiltrative ductal breast carcinoma. Cancer letters. 2001;169(1):69-75.

141.        Gharagozloo M, Ghaderi A. Immunomodulatory effect of concentrated lime juice extract on activated human mononuclear cells. Journal of ethnopharmacology. 2001;77(1):85-90.

142.        Ghaderi A, Talei A, Gharesi-Fard B, Farjadian SH, Amirzargar A, Vasei M. HLA-DBR 1 alleles and the susceptibility of Iranian patients with breast cancer. Pathology oncology research : POR. 2001;7(1):39-41.

143.        Ghaderi A, Talei A, Farjadian S, Mosalaei A, Doroudchi M, Kimura H. Germline BRCA1 mutations in Iranian women with breast cancer. Cancer letters. 2001;165(1):87-94.

144.        Doroudchi M, Dehaghani AS, Emad K, Ghaderi AA. Seroepidemiological survey of rubella immunity among three populations in Shiraz, Islamic Republic of Iran. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit. 2001;7(1-2):128-38.

2000 and ...

145.        Doroudchi M, Kremer K, Basiri EA, Kadivar MR, Van Soolingen D, Ghaderi AA. IS6110-RFLP and spoligotyping of Mycobacterium tuberculosis isolates in Iran. Scandinavian journal of infectious diseases. 2000;32(6):663-8.

146.        Amirghofran Z, Ghaderi AA. Characterization of a murine monoclonal antibody reactive with a leukocyte common antigen and its application to bone marrow transplantation. Transplantation proceedings. 1995;27(5):2657-8.

147.        Amirghofran Z, Ghaderi AA. Cross-linking of CD38 molecules induced expression of interleukin-2 receptor (IL-2R) and HLA-DR on human thymocytes. Roumanian archives of microbiology and immunology. 1995;54(4):265-70.

148.        Ghaderi AA, Gaudernack G, Stanworth DR. Cross-linking of a sequential epitope within the beta-chain of HLA-DR/DP molecules suppressing B lymphocyte growth and inducing homotypic cell aggregation. Immunology letters. 1994;39(2):113-9.

149.        Ghaderi AA, Stanworth DR. Production and characterization of two murine monoclonal antibodies directed against epitopes exclusive to soluble fragments of Fc epsilon RII/CD23. European journal of immunology. 1993;23(11):2909-15.

150.        Ghaderi AA, Stanworth DR. Epitope mapping of the site(s) of binding of Fc epsilon RII/CD23 within human IgE. Determination of the B lymphocyte-binding sites by use of synthetic peptides and anti-peptide antibodies representative of linear Fc sequences. Molecular immunology. 1993;30(18):1655-63.

151.        Ghaderi AA, Stanworth DR. Affinity-purified soluble Fc epsilon RII/CD23 derived from a culture supernatant of an EBV-immortalized B-cell line induced a monophasic fever in rabbits. Immunology. 1991;73(4):510-1.